Zobrazeno 1 - 10
of 149
pro vyhledávání: '"C, Genton"'
Autor:
Laurie Fraticelli, Elise Verot, Hans-Martin Späth, Marine C. Genton, Cédric Kempf, Celine Clement, Adeline Darlington-Bernard, Sylvain Roy, Claude Dussart, Gérard Mick, Florence Carrouel
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
IntroductionThe healthcare pathway is at the heart of public health organization concerns, but communication between the various players can be an obstacle. This work, produced by a French transdisciplinary team, offers a methodological approach base
Externí odkaz:
https://doaj.org/article/f262b10d023e48d381ee9bd300842043
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jens Huober, Anita Giobbie-Hurder, J. Lüthi, G. Berthod, A. Schönenberger, O. Pagani, M. Simcock, Peter Brauchli, C. Genton, Khalil Zaman, S. Aebi, Beat Thürlimann
Publikováno v:
Annals of Oncology, vol. 23, no. 6, pp. 1474-1481
Zaman, K; Thürlimann, B; Huober, J; Schönenberger, A; Pagani, O; Lüthi, J; Simcock, M; Giobbie-Hurder, A; Berthod, G; Genton, C; Brauchli, P; Aebi, S (2012). Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of oncology, 23(6), pp. 1474-1481. Oxford University Press 10.1093/annonc/mdr448
Zaman, K; Thürlimann, B; Huober, J; Schönenberger, A; Pagani, O; Lüthi, J; Simcock, M; Giobbie-Hurder, A; Berthod, G; Genton, C; Brauchli, P; Aebi, S (2012). Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of oncology, 23(6), pp. 1474-1481. Oxford University Press 10.1093/annonc/mdr448
BACKGROUND The risk of osteoporosis and fracture influences the selection of adjuvant endocrine therapy. We analyzed bone mineral density (BMD) in Swiss patients of the Breast International Group (BIG) 1-98 trial [treatment arms: A, tamoxifen (T) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73822c30544d5b00ec3e10c9ff561769
http://doc.rero.ch/record/300587/files/mdr448.pdf
http://doc.rero.ch/record/300587/files/mdr448.pdf
Autor:
C Genton
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 10
Autor:
C Genton
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum. 10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Schweizerische medizinische Wochenschrift. 126(44)
A 50-year-old woman rapidly developed ascites with jaundice and worsening of general condition. On admission a nodule of the left breast was noted. Workup showed slight anomalies in liver tests and led to the diagnosis of portal hypertension, without
Publikováno v:
Revue medicale de la Suisse romande. 114(3)
Autor:
D, Gillard Berguer, F, Stumpe, A, Fischer, M, Hurni, P, Ruchat, L, Kappenberger, H, Sadeghi, C, Genton, J J, Goy
Publikováno v:
Revue medicale de la Suisse romande. 112(2)
Autor:
Khalil Zaman, Stefan Aebi, Anita Giobbie-Hurder, Jens Huober, O. Pagani, J. Lüthi, A. Schönenberger, M. Simcock, Beat Thürlimann, C. Genton
Publikováno v:
Cancer Research. 69:5037-5037
Background: Bone health is a concern when treating early stage breast cancer patients with adjuvant aromatase inhibitors. Early detection of patients (pts) at risk of osteoporosis and fractures may be helpful for starting preventive therapies and sel